Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally respected journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in MEDLINE, PubMed, Embase, Scopus, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, EBSCOhost.com Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.



The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.

Announcements

 

Journal Announcement: CURRENT ONCOLOGY ANNOUNCES PARTNERSHIP WITH CANADIAN ASSOCIATION OF GENERAL PRACTITIONERS IN ONCOLOGY (CAGPO)

 

Current Oncology is pleased to partner with the Canadian Association of General Practitioners in Oncology (CAGPO) to publish its second series of articles aimed at summarizing the latest research and evidence on a given topic, and how it applies to current clinical practice for General Practitioners in Oncology (GPOs) in Canada. Dr. Genevieve Chaput (McGill University Health Centre, Montreal, QC) and Dr. Evan Lilly (Bluewater Health, Sarnia, ON) are the Guest Editors for this special series, which will launch in the February 2020 issue of the journal and run in six consecutive issues.  

 
Posted: 2019-12-12
 

Journal Announcement: Current Oncology's getting a new look in 2020!

 
Current Oncology will be upgrading to OJS 3 in early 2020!  
Posted: 2019-11-18 More...
 

Journal Announcement: CURRENT ONCOLOGY ANNOUNCES NEW MANAGING AND DEPUTY EDITORS

 

Current Oncology is pleased to announce that effective June 1, 2019 Dr. Habeeb Majeed will take on the role of Managing Editor and Dr. Sharlene Gill will assume the role of Deputy Editor.

 

After many years, our previous Managing Editor, Dr. Martin Chasen, has decided to step down and pursue other academic and clinical interests.  Dr. Chasen was instrumental in helping shape and build Current Oncology into a national journal of international reputation.  He helped steer its success in achieving a significant impact factor and its inclusion in both Pubmed and Medline.

 

We wish Dr. Chasen much success in his future ventures!

 

As we move forward, we have built a strong team with both Dr. Majeed and Dr. Gill at the helm.

Our future plans include, amongst others, building new relationships with key oncology organizations across Canada, and highlighting their influential work to our readers both in Canada and internationally.  Along with Dr. Majeed and Dr. Gill we aim to achieve these goals and strengthen the influence of Current Oncology to our over 350,000 viewers worldwide.

 

We have already ensured a smooth transition for all our stakeholders and we look forward to continuing to advance Current Oncology into the foreseeable future.

 
Posted: 2019-06-10
 
More Announcements...

Vol 26 (2019): Advances in Colorectal Cancer: Translating Best Evidence to Practice

This supplement was made possible through the support of Amgen Canada Inc., Bayer Canada, and Eli Lilly Canada. The opinions expressed in this material do not necessarily reflect the views of our supporters.

Current Oncology is thankful for their support of this project and for their ongoing commitment to research and education in colorectal cancer.

Table of Contents

Editorial(s)

Review Article(s)